CClinicalTrials.gg
RecruitingNCT05400707EMERGE VI-VIIUpdated Jan 26, 2026

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population

An observational study in Triage Risk Stratification, sponsored by University Hospital, Basel, Switzerland. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by University Hospital, Basel, Switzerland · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started May 2022; still recruiting 4 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
6,467
Ages
18 Years and older
Sex
All
01

Study summary

This study is to evaluate a tool capable of improved risk prediction regarding the 30-day mortality. The primary objective of this study is hospitalization, ICU-admission, morbidity and mortality in correlation with external validation of International Early Warning Score (IEWS) and decision-making processes regarding diagnosis, treatment and disposition in the ED.

Read the detailed description

Most emergency departments (EDs) perform an initial risk stratification of patients, called triage. Triage defines the process of systematically grouping patients according to their treatment priority on the base of algorithms in an environment with scarce health care resources. To this date no gold standard in triage risk stratification has been established. Most of the existing triage systems rely on the measurement of vital signs and a list of chief complaints. All of these systems have their shortcomings, especially in nonspecific ED presentations and in older patients. The primary objective of this study is hospitalization, ICU-admission, morbidity and mortality in correlation with external validation of International Early Warning Score (IEWS) and decision-making processes regarding diagnosis, treatment and disposition in the ED.

In this national single centre, prospective, consecutive, observational all-comers study patients entering the ED undergo triage and will be verbally informed about the study. First, each patient's vital signs (respiratory rate, oxygen saturation, heart rate, blood pressure, temperature) are measured and pain is rated on a scale of 0 to 10. In addition, the patient's level of consciousness is assessed using the AVPUC scale (alert, new confusion, verbal, pain, unresponsive, new confusion). Patients are asked to rate their own mobility between stable walking without aids or limited mobility with aids (walking aid, wheelchair, lying down). In addition, the patient's mobility is observed by the triage staff. The probability that the patient will be admitted as an inpatient is then assessed. A Clinical Frailty Scale (CFS) is also completed for patients over 65. After triage, patients are transferred to the treatment unit. Patients in need of immediate therapy, such as analgesia, will receive therapy before start of the interview. Patients will then be approached by a member of the study personnel and will be asked "which symptoms are you experiencing at the moment?". The question will be repeated 3 times, Answers will be recorded by ticking boxes in the CRF for a predefined list of 37 symptoms. Then, patients will be asked "which of the symptoms you reported is most important to you?". Patients are asked for their opinion on whether they should be discharged home after emergency treatment or whether they should stay in the hospital. Patients over the age of 65 are asked the following: "generally asked: what matters most to you at the moment?" and "why is that important for you?".

Then, the attending senior physicians are asked how injured/ill they rate the patients on a scale from 0 (not ill/injured) to 10 (very ill/injured). The senior physicians are asked questions about decision-making in the emergency department. With regard to diagnostics, they are asked what type of diagnostic decision is involved (simple or complex decision), whether there was time pressure when making the diagnostic decision and which factors formed the basis for their diagnostic decision (list of 14 factors, numbered according to importance if applicable). Regarding therapy, respondents were also asked what type of therapeutic decision was involved (simple or complex decision), whether there was time pressure in making the therapeutic decision, and which factors formed the basis for their therapeutic decision (list of 14 factors, numbered according to importance if applicable). Then the disposition of the patient (ambulatory or hospitalized) is defined. For ambulant patients, senior physicians are asked which factors formed the basis for their ambulant disposition (list of 9 factors, numbered according to importance if applicable). For hospitalized patients, the senior physicians are asked which factors were the basis for their inpatient disposition (list of 17 factors, numbered according to importance if applicable). Finally, the attending physicians are asked who made the disposition decision.

Follow-up to assess 30-day and 1-year mortality rate and date of death will start one year after the end of the inclusion period.

02

Conditions studied

  • Triage Risk Stratification

Keywords

  • risk prediction
  • Electronic triage systems (ETS)
  • undertriage
  • overtriage
  • 30-day mortality
03

In context

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 968 studies on the registry; 191 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population will consist of all patients presenting to the ED of the University Hospital Basel and awaiting triage.

Inclusion criteria

  • Patients presenting to the ED of the University Hospital Basel over a timecourse of 9 weeks in 2022, 2024, 2026

Exclusion criteria

Exclusion Criteria:

  • Obstetric, ophthalmologic, and paediatric patients will not be included
  • unwillingness to participate
  • insufficient ability to communicate with the study personnel.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
6,467 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients admitted to emergency ward of the University Hospital Basel.

    Diagnostic Test: Assessment of vital signs · Diagnostic Test: Assessment of patient mobility at presentation · Diagnostic Test: Assessment of level of consciousness by AVPUC scale · Diagnostic Test: Assessment of symptoms patients presenting when admitted to ED · Diagnostic Test: Assessment of what matters most in patients of 65 years and older · Diagnostic Test: Assessment of Decision-making in senior physicians · Diagnostic Test: Pain Numeric Rating Scale (NRS) · Diagnostic Test: Clinical Frailty Scale (CFS) · Diagnostic Test: Peripheral Perfusion Index (PPI) · Diagnostic Test: Capillary Refill Time (CRT) · Diagnostic Test: Mottling Score (MS) · Diagnostic Test: Mental health complaints · Diagnostic Test: Altered mental status - a vital sign

Interventions

  • Diagnostic testAssessment of vital signs

    heart rate, blood pressure, body temperature, respiration rate, peripheral capillary haemoglobin oxygen saturation)

  • Diagnostic testAssessment of patient mobility at presentation

    Patients are asked how they assess their own mobility: - Stable walking without aids or limited mobility with aids (walking aid, wheelchair, lying down).

  • Diagnostic testAssessment of level of consciousness by AVPUC scale

    Assessment of level of consciousness by AVPUC scale (alert, new confusion, verbal, pain, unresponsive, new confusion)

  • Diagnostic testAssessment of symptoms patients presenting when admitted to ED

    Questionnaire with a predefined list of 37 symptoms

  • Diagnostic testAssessment of what matters most in patients of 65 years and older

    Patients over the age of 65 are asked the following: "generally asked: what matters most to you at the moment?" and "why is that important for you?".

  • Diagnostic testAssessment of Decision-making in senior physicians

    Questionnaire consisting of 10 questions about the decision-making processes in the emergency department and the factors that form the basis of their decisions regarding the diagnosis, treatment, and disposition of the patient.

  • Diagnostic testPain Numeric Rating Scale (NRS)

    The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain ('0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine"))

  • Diagnostic testClinical Frailty Scale (CFS)

    The CFS is a commonly used score to assess frailty. It was developed within the Canadian Study of Health and Aging and consists of a 9-level ordinal scale ranging from very fit (score 1) to living with very severe frailty (score 8), and score 9 reserved for those who are terminally ill.

  • Diagnostic testPeripheral Perfusion Index (PPI)

    The PPI is derived from the photoplethysmography signal of pulse oximetry and represents the ratio between the pulsatile component (arterial compartment) and the non-pulsatile component (non-arterial tissues) of the light detected by the sensor. PPI can provide information for resuscitation in shock, outcome prediction in critically ill patients and may serve as an adjunct triage tool.

  • Diagnostic testCapillary Refill Time (CRT)

    CRT provides a standardized assessment of capillary flow dynamics and is most assessed at the fingertip in clinical practice. A prolonged CRT in patients with septic, traumatic and cardiogenic shock has been associated with increased mortality and might be used as a resuscitation target in patients with septic shock.

  • Diagnostic testMottling Score (MS)

    Mattling is a characteristic discoloration of the skin resulting from reduced skin blood flow and has been shown to be associated with tissue hypoperfusion. The MS provides a simple scale (0-5) to characterize the extent of skin mottling around the knee and the severity of mottling is associated with adverse outcomes.

  • Diagnostic testMental health complaints

    Mental health complaints require safe, efficient risk stratification to distinguish primary psychiatric conditions from medical causes or comorbidities. Because current medical screening practices are inconsistent and unvalidated, this study will use prospective routine ED data to evaluate triage assessments of psychiatric likelihood and identify opportunities for standardized, evidence-based screening.

  • Diagnostic testAltered mental status - a vital sign

    Delirium is a common and high-risk condition in older ED patients, and early detection is crucial to improve short- and long-term outcomes. This study will use routinely collected ED screening data (modified Confusion Assessment Method for the Emergency Department (mCAM-ED) and the four-item Abbreviated Mental Test (AMT-4)) to describe delirium prevalence and evaluate delirium identification in the emergency setting.

06

What researchers measure

Primary outcomes

  1. 30-day mortality

    30-day mortality is defined as death within 30 days of the day of presentation to the ED

    Time frame: within 30 days of the day of presentation to the ED

Secondary outcomes

  1. Number of hospitalizations

    Hospitalization is defined as the direct admission from the ED to any hospital in-patient department with a stay of over 24 hours

    Time frame: at baseline (= day of presentation to the ED)

  2. Number of ICU-admissions

    ICU-admission is defined as any direct admission to the ICU of the University Hospital of Basel

    Time frame: at baseline (= day of presentation to the ED)

  3. Death rate (In-hospital mortality)

    In-hospital mortality is defined as death occurring during presentation to the ED and hospital discharge

    Time frame: from day of presentation to the ED to day of hospital discharge (assessed within 365 days of the day of presentation to the ED)

  4. 100-day mortality

    100-day mortality is defined as death within 100 days of the day of presentation to the ED

    Time frame: within 100 days of the day of presentation to the ED

  5. Number of institutionalisations

    Institutionalisation is defined as no time spent at home during 365 days following presentation

    Time frame: within 100 days of the day of presentation to the ED

  6. Morbidity

    Acute Morbidity defined as framework of fourteen rationales: administration of antibiotics, virostatics, antifungals, immunosuppressives, diuretics, anticoagulants, antihypertensives, and procoagulants; the need for invasive interventions, or prolonged monitoring; new neurological deficits, or seizures; fractures, or self-harm

    Time frame: within 100 days of the day of presentation to the ED

07

Study locations

1 of 1 sites recruiting
  • Department of Emergency Medicine, University Hospital Basel
    Basel, 4031, Switzerland
    • Roland Bingisser, Prof. Dr. med. · Contact · roland.bingisser@usb.ch · +41 61 265 58 30
    • Christian Nickel, Prof. Dr. med. · Contact · christian.nickel@usb.ch · +41 61 265 53 15
    • Roland Bingisser, Prof. Dr. med. · Principal investigator
    • Christian Nickel, Prof. Dr. med. · Sub investigator
    Recruiting
08

References and documents

Publications

  • Riedel HB, Espejo T, Dreher-Hummel T, Bingisser R, Nickel CH. Screening for elder mistreatment in a Swiss emergency department: a prospective cohort study. Swiss Med Wkly. 2024 Jun 10;154:3775. doi: 10.57187/s.3775. PubMed 38875501 ↗
  • Albrecht R, Espejo T, Riedel HB, Nissen SK, Banerjee J, Conroy SP, Dreher-Hummel T, Brabrand M, Bingisser R, Nickel CH. Clinical Frailty Scale at presentation to the emergency department: interrater reliability and use of algorithm-assisted assessment. Eur Geriatr Med. 2024 Feb;15(1):105-113. doi: 10.1007/s41999-023-00890-y. Epub 2023 Nov 16. PubMed 37971677 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05400707
Lead sponsor
University Hospital, Basel, Switzerland
Responsible party
Sponsor
First posted
Jun 1, 2022
Start date
May 17, 2022
Primary completion
May 27, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 26, 2026

Study contacts

Roland Bingisser, Prof. Dr. med.
Contact
roland.bingisser@usb.ch
+41 61 265 58 30
Christian Nickel, Prof. Dr. med.
Contact
christian.nickel@usb.ch
+41 61 265 53 15
Roland Bingisser, Prof. Dr. med.
principal investigator · University Hospital Basel, Department of Emergency Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion